Readiness for change · people with substance use (adults, young adults, adolescents)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Retention in treatment · people with substance use (adults, young adults, adolescents)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Extent of substance use at short‐term · people with substance use (adults, young adults, adolescents)
2 findings from 1 review
Extent of substance use at medium‐term · people with substance use (adults, young adults, adolescents)
1 finding from 1 review
Extent of substance use at long‐term · people with substance use (adults, young adults, adolescents)
1 finding from 1 review
Readiness to change (0‐ to 3‐month · people with substance use (adults, young adults, adolescents)
1 finding from 1 review
Retention in treatment · people with substance use (adults, young adults, adolescents)
1 finding from 1 review
Extent of substance use at medium‐term · people with substance use (adults, young adults, adolescents)
1 finding from 1 review
Extent of substance use at long‐term · people with substance use (adults, young adults, adolescents)
1 finding from 1 review
Readiness for change · people with substance use (adults, young adults, adolescents)
1 finding from 1 review
Retention in treatment · people with substance use (adults, young adults, adolescents)
1 finding from 1 review
Extent of substance use at short‐term · people with substance use (adults, young adults, adolescents)
2 findings from 1 review
Extent of substance use at medium‐term · people with substance use (adults, young adults, adolescents)
1 finding from 1 review
Relapse: return to any drinking at end of treatment · alcohol use disorder
Summary of findings table ‐ Baclofen probably leads to lower relapse: return to any drinking at end of treatment compared with placebo (moderate certainty).
1 finding from 1 review
Dropout · alcohol use disorder
It is very uncertain whether summary of findings table ‐ Baclofen changes dropouts at end of treatment compared with acamprosate (very low certainty).
1 finding from 1 review
Dropouts due to adverse events · alcohol use disorder
It is very uncertain whether summary of findings table ‐ Baclofen changes dropouts due to adverse events compared with acamprosate (very low certainty).
1 finding from 1 review
Relapse: return to any drinking at end of treatment · alcohol use disorder
It is very uncertain whether summary of findings table ‐ Baclofen changes relapse: return to any drinking at end of treatment compared with naltrexone (very low certainty).
1 finding from 1 review
Adverse events: number of participants with ≥ 1 adverse event at end of treatment · alcohol use disorder
It is very uncertain whether summary of findings table ‐ Baclofen changes adverse events: number of participants with ≥ 1 adverse event at end… compared with naltrexone (very low certainty).
1 finding from 1 review
Dropout · alcohol use disorder
It is very uncertain whether summary of findings table ‐ Baclofen changes dropouts at end of treatment compared with naltrexone (very low certainty).
1 finding from 1 review
Frequency of use % days abstinence at the end of treatment · alcohol use disorder
1 finding from 1 review